Call for Abstract

Acadamia

11th International Conference on Medicinal Chemistry and Pharmaceutical Technology, will be organized around the theme “Deliberate the challenges in the New era of Optimizing Medicinal Chemistry & Drug Design Research Reforms”

Euro Medicinal Chemistry 2019 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Euro Medicinal Chemistry 2019

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

The pharmaceutical industry has bump into substantial difficulties in its efforts to withstand the productivity and profitability of drug discovery during the process of discovering novel drug targets. The pharmaceutical industry which is mainly of research-based plays an exclusive role in the discovery and development of new medicines and vaccines to prevent and treat diseases or disorders and thereby improving the lives and health of the patients throughout the world. It has given its key contribution to global health and is turning fundamental research into innovative treatments. Industry’s success relies on continuous innovation for the prevention and treatment of common health problems, complex medical emergencies, and neglected diseases, and for improvements in existing treatments. Existing Drug Targets purposes to cover the modern and most outstanding expansions on the medicinal chemistry and pharmacology of the discovered and developed molecular drug targets. For example, is the disease specific proteins, receptors, enzymes, genes.

Meet leading Medicinal Chemists, Drug Discovery Scientists, Organic Chemists, Pharma Experts, Pharmacologists, Toxicologists at Medicinal Chemistry ConferencesPrague Medicinal Chemistry ConferencesPharmaceutical Technology Conferences, Europe, USA, UK, China Japan Medicinal Chemistry Conferences held during April 01-02, Prague, Czech Republic.

 

  • Track 1-1Targeted Protein Degradation
  • Track 1-2DNA Encoded Libraries
  • Track 1-3Hit-to-Lead Optimization
  • Track 1-4Predictive Toxicology – Improving Compound Safety
  • Track 1-5Small Molecule Immuno-Oncology
  • Track 1-6Artificial Intelligence in Medicinal Chemistry
  • Track 1-7Optimizing Outsourcing Activities

Drug Discovery is the identification and documentation of novel active chemical compounds. The identified novel active chemical compounds are called as "hits", which are typically found by assaying of the chemical compounds for a desired biological activity. The discovery of new generation antimicrobials against multidrug resistant strains of bacteria such as tuberculosis is advancing by extensive use of those modern tools. Natural products chemistry has been re-emerging as a highly promising provider of the sufficiently sophisticated lead structures for drug discovery. “Structural biology”, “computational biology”, “chemical biology”, and “chemical genetics” are now fully incorporated into modern drug discovery through target-based approaches.

Meet leading Medicinal Chemists, Drug Discovery Scientists, Organic Chemists, Pharma Experts, Pharmacologists, Toxicologists at Medicinal Chemistry ConferencesPrague Medicinal Chemistry ConferencesPharmaceutical Technology Conferences, Europe, USA, UK, China Japan Medicinal Chemistry Conferences held during April 01-02, Prague, Czech Republic

  • Track 2-1Fragment-Based Drug Discovery
  • Track 2-2Macrocyclics & Constrained Peptides
  • Track 2-3Biophysical Approaches for Drug Discovery
  • Track 2-4Small Molecules for Cancer Immunotherapy
  • Track 2-5Inflammation Inhibitors
  • Track 2-6Kinase Inhibitor Chemistry
  • Track 2-7Blood-Brain Penetrate Inhibitors
  • Track 2-8GPCR-Targeted Drug Design
  • Track 2-9Protein-Protein Interactions

Meet leading Medicinal Chemists, Drug Discovery Scientists, Organic Chemists, Pharma Experts, Pharmacologists, Toxicologists at Medicinal Chemistry ConferencesPrague Medicinal Chemistry ConferencesPharmaceutical Technology Conferences, Europe, USA, UK, China Japan Medicinal Chemistry Conferences held during April 01-02, Prague, Czech Republic

  • Track 3-1Biomolecules
  • Track 3-2Preparation of Natural products
  • Track 3-3Metal Complexes creation
  • Track 3-4Asymmetric synthesis
  • Track 3-5Organometallic chemistry
  • Track 3-6Nucleotide chemistry
  • Track 3-7Chemogenomics and Chemical Biology for Target Identification and Validation
  • Track 3-8 Assemblies of macrolide-mimetics
  • Track 3-9Spiro– medium- and large(macro) heterocyclic systems
  • Track 3-10 Isosteric replacements of amino acids, di-/tri-peptides

Research and Development can be defined as innovative and experimental work undertaken on a systematic basis to increase the stock of knowledge including search of new molecules, synthesis and modification of known molecules and also some methods to increase production rate by adopting diverse techniques. Superior quality R&D work requires an excellent back up from what are called the support functions. These include analytical, information services and technology, intellectual property and regulatory affairs. The management of these functions, especially the laboratory based analytical service, requires many of the skills associated with core R&D and will therefore not be treated separately in any detail, except to point out their relationship and role within the organization.

Meet leading Medicinal Chemists, Drug Discovery Scientists, Organic Chemists, Pharma Experts, Pharmacologists, Toxicologists at Medicinal Chemistry ConferencesPrague Medicinal Chemistry ConferencesPharmaceutical Technology Conferences, Europe, USA, UK, China Japan Medicinal Chemistry Conferences held during April 01-02, Prague, Czech Republic

  • Track 4-1Challenges in Pharmaceutical Formulations
  • Track 4-2Ethnopharmacology
  • Track 4-3Pharmaceutical Chemistry
  • Track 4-4Opportunities in Pharmaceutical Management
  • Track 4-5Pharmaceutical Technology Assessment
  • Track 4-6Bioinformatics and Computational Biology
  • Track 4-7Pharmaceutical industry
  • Track 4-8Pharmaceutical Packaging and labeling
  • Track 4-9Scope of Pharmaceutical Research
  • Track 4-10Biosimilars & Regulatory Affairs

Meet leading Medicinal Chemists, Drug Discovery Scientists, Organic Chemists, Pharma Experts, Pharmacologists, Toxicologists at Medicinal Chemistry ConferencesPrague Medicinal Chemistry ConferencesPharmaceutical Technology Conferences, Europe, USA, UK, China Japan Medicinal Chemistry Conferences held during April 01-02, Prague, Czech Republic

  • Track 5-1Receptor theory
  • Track 5-2Molecular Modeling and Computational Chemistry
  • Track 5-3Quantum Mechanics and Molecular Mechanics
  • Track 5-4Steepest Descent Method
  • Track 5-5Conjugate Gradient Method
  • Track 5-6 Structure-Based Computer-Aided Drug Design
  • Track 5-7Ligand-Based Computer-Aided Drug Design
  • Track 5-8Molecular Docking
  • Track 5-9Database Searching
  • Track 5-10de novo Drug Design

Meet leading Medicinal Chemists, Drug Discovery Scientists, Organic Chemists, Pharma Experts, Pharmacologists, Toxicologists at Medicinal Chemistry ConferencesPrague Medicinal Chemistry ConferencesPharmaceutical Technology Conferences, Europe, USA, UK, China Japan Medicinal Chemistry Conferences held during April 01-02, Prague, Czech Republic

  • Track 6-1Bioanalytical Techniques
  • Track 6-2Hyphenated Techniques
  • Track 6-3Chromatography Methods
  • Track 6-4Electrophoresis
  • Track 6-5Ligand Binding Assays
  • Track 6-6Mass Spectrometry
  • Track 6-7Nuclear Magnetic Resonance
  • Track 6-8Sample preparation and extraction
  • Track 6-9Natural Products Synthesis
  • Track 6-10Synthetic methodology
  • Track 6-11Catalysis
  • Track 6-12New synthetic technologies
  • Track 6-13Medicinal Chemistry and Chemical Biology
  • Track 6-14Synthesis of nano and functionalized Materials

The practice of making drugs and medicines for consumers. Pharmaceutical manufacturing workers create medicines from basic ingredients and synthesized materials. Most manufacturing workers work for large pharmaceutical companies and mix ingredients and package medicines for delivery. They are several types of drug administration and they can be mainly classified into parenteral, sublingual, inhalation, oral, transdermal, topical, and rectal. The route of administration depends upon the bioavailability of the drug.

Meet leading Medicinal Chemists, Drug Discovery Scientists, Organic Chemists, Pharma Experts, Pharmacologists, Toxicologists at Medicinal Chemistry ConferencesPrague Medicinal Chemistry ConferencesPharmaceutical Technology Conferences, Europe, USA, UK, China Japan Medicinal Chemistry Conferences held during April 01-02, Prague, Czech Republic

  • Track 7-1Pharmaceutics and Pharmaceutical Technology
  • Track 7-2Pharmacovigilance and Drug Safety
  • Track 7-3Clinical Pharmacy
  • Track 7-4Hospital Pharmacy
  • Track 7-5Industrial Pharmacy
  • Track 7-6Innovation in Drug Delivery Technologies
  • Track 7-7Advancements in Drug Targeting & Drug Development
  • Track 7-8Advances in Bioavailability and Bioequivalence
  • Track 7-9Insights of Pharmacology and Pharma Engineering
  • Track 7-10Pharmaceutical Nanotechnology

Meet leading Medicinal Chemists, Drug Discovery Scientists, Organic Chemists, Pharma Experts, Pharmacologists, Toxicologists at Medicinal Chemistry ConferencesPrague Medicinal Chemistry ConferencesPharmaceutical Technology Conferences, Europe, USA, UK, China Japan Medicinal Chemistry Conferences held during April 01-02, Prague, Czech Republic

  • Track 8-1Drug Discovery Chemistry – where are we heading
  • Track 8-2Target Validation using Medicinal Chemistry tools
  • Track 8-3Optimizing hit to lead optimization quality and timescale
  • Track 8-4Best Practice Case Studies
  • Track 8-5Data for decision making
  • Track 8-6Protein Degradation Strategies
  • Track 8-7Future of Medicinal Chemistry

Meet leading Medicinal Chemists, Drug Discovery Scientists, Organic Chemists, Pharma Experts, Pharmacologists, Toxicologists at Medicinal Chemistry ConferencesPrague Medicinal Chemistry ConferencesPharmaceutical Technology Conferences, Europe, USA, UK, China Japan Medicinal Chemistry Conferences held during April 01-02, Prague, Czech Republic

  • Track 9-1Kinase Inhibitors
  • Track 9-2Approaches to Optimization and Characterization
  • Track 9-3Inhibitors for Rare Diseases
  • Track 9-4Recent Advances in Screening Approaches to Lead Identification
  • Track 9-5Novel Approaches to Anti-Infective Drug Discovery and Liver Disease
  • Track 9-6Targeting RNA
  • Track 9-7Macrocycles in Drug Design
  • Track 9-8Advances in Targeting Immuno-Inflammation
  • Track 9-9Synthesis Applications and ADME in Drug Discovery

Meet leading Medicinal Chemists, Drug Discovery Scientists, Organic Chemists, Pharma Experts, Pharmacologists, Toxicologists at Medicinal Chemistry ConferencesPrague Medicinal Chemistry ConferencesPharmaceutical Technology Conferences, Europe, USA, UK, China Japan Medicinal Chemistry Conferences held during April 01-02, Prague, Czech Republic

  • Track 10-1Frontiers in Catalysis
  • Track 10-2Aggressive Bond Disconnections in Total Synthesis
  • Track 10-3Chemical Probes for Characterizing Biology
  • Track 10-4Synthetic Biology for Natural Products
  • Track 10-5Advances in Drug Discovery
  • Track 10-6Natural Product Discovery and Biosynthesis
  • Track 10-7Combining Synthesis and Biosynthesis to Construct Complex Molecules
  • Track 10-8New Directions in Antibiotic Discovery and Development
  • Track 10-9Accessing Complex Molecules
  • Track 10-10Structure-biodegradability relationship
  • Track 10-11Diversity-Oriented Synthesis

Drug delivery systems can be referred as engineered technologies used for the targeted delivery. Drug Delivery systems are intended to achieve controlled and prolonged release of therapeutic agents to produce intended efficacy. The search for innovative approaches of drug delivery and new modes of action is a rapidly developing field. Many small molecule drugs (eg: aspirin) are associated with non-specific action, toxicity, efficacy only at high concentrations, a narrow therapeutic index, and a short half-life. On the other hand, peptide (eg: glucagon-like peptide) and protein (eg: erythropoietin) drugs are potent, specific in action and less toxic.

Meet leading Medicinal Chemists, Drug Discovery Scientists, Organic Chemists, Pharma Experts, Pharmacologists, Toxicologists at Medicinal Chemistry ConferencesPrague Medicinal Chemistry ConferencesPharmaceutical Technology Conferences, Europe, USA, UK, China Japan Medicinal Chemistry Conferences held during April 01-02, Prague, Czech Republic

 

  • Track 11-1Pre-formulation and Formulation Studies
  • Track 11-2Novel Drug Delivery Systems
  • Track 11-3Biomaterials and Drug Delivery Systems
  • Track 11-4Medical Devices for Drug Delivery Systems
  • Track 11-5Immunopharmacology and Immunotoxicology
  • Track 11-6Bioinformatics and Computational Biology
  • Track 11-7Smart Drug Delivery Systems
  • Track 11-8Advancement in Drug Regulatory Affairs

Meet leading Medicinal Chemists, Drug Discovery Scientists, Organic Chemists, Pharma Experts, Pharmacologists, Toxicologists at Medicinal Chemistry ConferencesPrague Medicinal Chemistry ConferencesPharmaceutical Technology Conferences, Europe, USA, UK, China Japan Medicinal Chemistry Conferences held during April 01-02, Prague, Czech Republic

  • Track 12-1Organocatalysis
  • Track 12-2Flow-chemistry approaches to the synthesis of key targets
  • Track 12-3Applications of organometallic compounds in synthesis and catalysis
  • Track 12-4Stereoselective synthesis
  • Track 12-5Synthesis and property of functional molecules and organic materials
  • Track 12-6Sustainable and Green synthetic and catalytic methods
  • Track 12-7Process development of key pharmaceutical targets
  • Track 12-8Synthesis in Medicinal chemistry and chemical biology
  • Track 12-9Biocatalysis in synthesis
  • Track 12-10Computational tools for synthesis and catalysis
  • Track 12-11Polymer synthesis

Meet leading Medicinal Chemists, Drug Discovery Scientists, Organic Chemists, Pharma Experts, Pharmacologists, Toxicologists at Medicinal Chemistry ConferencesPrague Medicinal Chemistry ConferencesPharmaceutical Technology Conferences, Europe, USA, UK, China Japan Medicinal Chemistry Conferences held during April 01-02, Prague, Czech Republic

  • Track 13-1Addressing Preclinical Toxicity
  • Track 13-2Advances in Lead Generation
  • Track 13-3Advances in Synthetic Methods
  • Track 13-4Alternative Modalities
  • Track 13-5Challenges and Opportunities in Fragment Based Drug Discovery
  • Track 13-6Chemical Biology in Drug and Target Discovery
  • Track 13-7Drug Discovery Tales
  • Track 13-8Late Stage Functionalization
  • Track 13-9High pressure cryogenic reactions
  • Track 13-10Enzymatic reactions
  • Track 13-11Cascade addition-cyclization
  • Track 13-12Multi-component reactions
  • Track 13-13One-pot Syntheses

The pharmaceutical industry channels an important proportion of total research in most developed countries. In Europe, for example, it represents about 13% of total R&D. In recent years, pharmaceutical companies have been accused of devoting their resources mainly to minor improvements over existing medications that require short clinical trials and have a small risk of not being approved. The support functions were an integral part of a large company’s R&D function but nowadays they are most likely to be outsourced under contract to external organizations specializing in a particular service, especially if these activities are not seen to offer a competitive advantage to the company.

Meet leading Medicinal Chemists, Drug Discovery Scientists, Organic Chemists, Pharma Experts, Pharmacologists, Toxicologists at Medicinal Chemistry ConferencesPrague Medicinal Chemistry ConferencesPharmaceutical Technology Conferences, Europe, USA, UK, China Japan Medicinal Chemistry Conferences held during April 01-02, Prague, Czech Republic

  • Track 14-1Recent Development of Pharmaceutical Materials
  • Track 14-2Recent developments In Pharmaceutics & Biopharmaceutics
  • Track 14-3Advancements in Pharmaceutical Biotechnology
  • Track 14-4Approaches in Pharmaceutical Nanotechnology
  • Track 14-5Innovations in Pharmaceutical Technology
  • Track 14-6Advancements in Pharmaceutical Manufacturing
  • Track 14-7Development in Pharmaceutical Engineering
  • Track 14-8Pharmacological Technology advances

Meet leading Medicinal Chemists, Drug Discovery Scientists, Organic Chemists, Pharma Experts, Pharmacologists, Toxicologists at Medicinal Chemistry ConferencesPrague Medicinal Chemistry ConferencesPharmaceutical Technology Conferences, Europe, USA, UK, China Japan Medicinal Chemistry Conferences held during April 01-02, Prague, Czech Republic

  • Track 15-1Design, manufacture and use of efficacious dosage forms
  • Track 15-2Types of Formulation: Enteral, Parenteral and Topical
  • Track 15-3Water-miscible formulations
  • Track 15-4Other formulations
  • Track 15-5Pesticide formulation
  • Track 15-6Recent Developments in Dosage Form Design
  • Track 15-7Establishing the Bioequivalence of Pharmaceutical Products

Meet leading Medicinal Chemists, Drug Discovery Scientists, Organic Chemists, Pharma Experts, Pharmacologists, Toxicologists at Medicinal Chemistry ConferencesPrague Medicinal Chemistry ConferencesPharmaceutical Technology Conferences, Europe, USA, UK, China Japan Medicinal Chemistry Conferences held during April 01-02, Prague, Czech Republic

  • Track 16-1ADME (adsorption, distribution, metabolism and excretion)Of drugs
  • Track 16-2Metabolism and toxicology
  • Track 16-3Antiviral and antimicrobial activity
  • Track 16-4Drug receptor interaction
  • Track 16-5Kojic acid as a tyrosine inhibitor
  • Track 16-6Components of ADME
  • Track 16-7Pharmacokinetics and process of ADME

Meet leading Medicinal Chemists, Drug Discovery Scientists, Organic Chemists, Pharma Experts, Pharmacologists, Toxicologists at Medicinal Chemistry ConferencesPrague Medicinal Chemistry ConferencesPharmaceutical Technology Conferences, Europe, USA, UK, China Japan Medicinal Chemistry Conferences held during April 01-02, Prague, Czech Republic

  • Track 17-1Analytical Techniques for Clinical Chemistry
  • Track 17-2Chemical Analysis
  • Track 17-3Electrochemical Analysis
  • Track 17-4Spectroscopy
  • Track 17-5Separation Techniques

Meet leading Medicinal Chemists, Drug Discovery Scientists, Organic Chemists, Pharma Experts, Pharmacologists, Toxicologists at Medicinal Chemistry ConferencesPrague Medicinal Chemistry ConferencesPharmaceutical Technology Conferences, Europe, USA, UK, China Japan Medicinal Chemistry Conferences held during April 01-02, Prague, Czech Republic

  • Track 18-1Foundation in Paediatric Pharmaceutical Care
  • Track 18-2Equipment and Technologies for the Pharmaceutical Industry
  • Track 18-3Validation & Transfer of Methods for Biopharmaceutical Analysis
  • Track 18-4Stability and Shelf-life of Pharmaceuticals
  • Track 18-5Pharmaceutical Microbiology
  • Track 18-6Corporate Compliance & Transparency in the Pharmaceutical Industry

Meet leading Medicinal Chemists, Drug Discovery Scientists, Organic Chemists, Pharma Experts, Pharmacologists, Toxicologists at Medicinal Chemistry ConferencesPrague Medicinal Chemistry ConferencesPharmaceutical Technology Conferences, Europe, USA, UK, China Japan Medicinal Chemistry Conferences held during April 01-02, Prague, Czech Republic

  • Track 19-1Rational Prescribing
  • Track 19-2Adverse drug effects
  • Track 19-3Drug interactions
  • Track 19-4Drug Development
  • Track 19-5Pharmacogenomics
  • Track 19-6Structure-guided Drug Design
  • Track 19-7Molecular Cloning of Drug Targets
  • Track 19-8Cellular Basis of Pharmacokinetics
  • Track 19-9Cellular Basis of Pharmacokinetics
  • Track 19-10Receptors and Modulation of Their Response
  • Track 19-11Drug–Receptor Interactions
  • Track 19-12G-Protein-Coupled Receptors
  • Track 19-13Pharmacology of Transcription
  • Track 19-14Intercellular communication
  • Track 19-15Pharmacology of defense process

The role of organic chemistry in the pharmaceutical development of novel drug molecules continues to be one of the key drivers in the process of drug discovery and new drug targets. However, the precise nature of that role played by organic chemistry is undergoing a visible change, not only because of the new synthetic methods and but also by the technologies now available to the synthetic chemist as well as the medicinal chemist, but also in numerous key areas, particularly in drug metabolism and chemical toxicology. Medicinal chemists around the world deal with more rapid turnaround of testing the data of molecules that influences their day-to-day decisions.

Meet leading Medicinal Chemists, Drug Discovery Scientists, Organic Chemists, Pharma Experts, Pharmacologists, Toxicologists at Medicinal Chemistry ConferencesPrague Medicinal Chemistry ConferencesPharmaceutical Technology Conferences, Europe, USA, UK, China Japan Medicinal Chemistry Conferences held during April 01-02, Prague, Czech Republic

  • Track 20-1Virtual Screening
  • Track 20-2QSAR (Quantitative Structure-Activity Relationship)
  • Track 20-3Target Structure-Based Design
  • Track 20-4Fragment-Based Drug Design

Meet leading Medicinal Chemists, Drug Discovery Scientists, Organic Chemists, Pharma Experts, Pharmacologists, Toxicologists at Medicinal Chemistry ConferencesPrague Medicinal Chemistry ConferencesPharmaceutical Technology Conferences, Europe, USA, UK, China Japan Medicinal Chemistry Conferences held during April 01-02, Prague, Czech Republic

  • Track 21-1ADCs – Targeted delivery
  • Track 21-2Immuno-oncology
  • Track 21-3Small-molecule targeting of RNAs
  • Track 21-4Preventative Toxicology
  • Track 21-5Phenotypic screening
  • Track 21-6SBDD Case studies
  • Track 21-7Molecules with predictable in vivo and safety profiles
  • Track 21-8Macrocyclic compounds

“Drug discovery” has historically been a stronghold of chemistry, especially natural products chemistry and synthetic organic chemistry. Chemistry is thus inherently well-positioned to have a major impact on drug discovery, since other disciplines cannot create novel small molecules. In other words, “drug discovery and development” cannot happen without chemists.

Meet leading Medicinal Chemists, Drug Discovery Scientists, Organic Chemists, Pharma Experts, Pharmacologists, Toxicologists at Medicinal Chemistry ConferencesPrague Medicinal Chemistry ConferencesPharmaceutical Technology Conferences, Europe, USA, UK, China Japan Medicinal Chemistry Conferences held during April 01-02, Prague, Czech Republic

  • Track 22-1Targeted protein degradation / PROTACs
  • Track 22-2DNA Encoded Libraries
  • Track 22-3Hit-to-Lead Optimization
  • Track 22-4Predictive Toxicology – Improving Compound Safety
  • Track 22-5Artificial Intelligence in Medicinal Chemistry
  • Track 22-6Optimizing Outsourcing Activities

There are various delivery approaches that can be used to maximize therapeutic efficacy and minimize side effects, by impacting absorption, distribution, metabolism, and elimination (ADME) of a drug compound. For those drugs with poor water solubility or low permeability, techniques such as amorphous solid dispersion, liposomes, and complexations have been used to improve their oral bioavailability. Modified release (MR) formulations have been widely used to improve patient compliance, as well as to reduce side effects, especially for those drugs with short half-lives or narrow therapeutic windows.

Meet leading Medicinal Chemists, Drug Discovery Scientists, Organic Chemists, Pharma Experts, Pharmacologists, Toxicologists at Medicinal Chemistry ConferencesPrague Medicinal Chemistry ConferencesPharmaceutical Technology Conferences, Europe, USA, UK, China Japan Medicinal Chemistry Conferences held during April 01-02, Prague, Czech Republic

  • Track 23-1Drug Discovery and Development
  • Track 23-2Pharmacoeconomics
  • Track 23-3Nanomedicine and Nanotechnology
  • Track 23-4Clinical Pharmacology and Therapeutics
  • Track 23-5Applications of Polymers
  • Track 23-6Pharmacoepidemiology

The synthesis of each molecule was first carried out on a small scale (probably milligrams) in the laboratory, followed much later by development of safe, efficient, and scalable methods to provide kilograms of active pharmaceutical ingredient (API) that was incorporated into dosage forms for administration to patients. It is critical to point out that an early step in the complex process of drug discovery was the synthesis of a molecule that tested a hypothesis faced by the project team. This required a medicinal chemist to use organic chemistry training and experience to conceive of a compound and then employ appropriate reactions to furnish the desired target and synthesize a suitable number of derivatives to optimize the spectrum of properties associated with drug like candidates.

Meet leading Medicinal Chemists, Drug Discovery Scientists, Organic Chemists, Pharma Experts, Pharmacologists, Toxicologists at Medicinal Chemistry ConferencesPrague Medicinal Chemistry ConferencesPharmaceutical Technology Conferences, Europe, USA, UK, China Japan Medicinal Chemistry Conferences held during April 01-02, Prague, Czech Republic

  • Track 24-1New reagents, strategies, catalysts and concepts for organic synthesis
  • Track 24-2Mechanistic organic chemistry
  • Track 24-3Computational chemistry
  • Track 24-4Supramolecular chemistry
  • Track 24-5Medicinal chemistry
  • Track 24-6Drug discovery
  • Track 24-7Total synthesis of natural products
  • Track 24-8Heterocyclic compounds
  • Track 24-9Synthesis and functional properties of molecules
  • Track 24-10Asymmetric synthesis
  • Track 24-11Green chemistry

Meet leading Medicinal Chemists, Drug Discovery Scientists, Organic Chemists, Pharma Experts, Pharmacologists, Toxicologists at Medicinal Chemistry ConferencesPrague Medicinal Chemistry ConferencesPharmaceutical Technology Conferences, Europe, USA, UK, China Japan Medicinal Chemistry Conferences held during April 01-02, Prague, Czech Republic

  • Track 25-1Structural and in-Silico Chemistry
  • Track 25-2Chemical Biology for Drug Discovery
  • Track 25-3Pain Medications and their SAR
  • Track 25-4Recent Advances in Targeting Autophagy
  • Track 25-5Photo-redox Catalysis
  • Track 25-6Advances in Synthesis and Medicinal Chemistry